SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-030103
Filing Date
2023-03-08
Accepted
2023-03-08 16:10:26
Documents
14
Period of Report
2023-03-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm238871d1_8k.htm   iXBRL 8-K 33215
2 EXHIBIT 99.1 tm238871d1_ex99-1.htm EX-99.1 15219
6 GRAPHIC tm238871d1_ex99-1img001.jpg GRAPHIC 13084
  Complete submission text file 0001104659-23-030103.txt   248362

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA atxi-20230307.xsd EX-101.SCH 3033
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20230307_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20230307_pre.xml EX-101.PRE 22595
8 EXTRACTED XBRL INSTANCE DOCUMENT tm238871d1_8k_htm.xml XML 3590
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38114 | Film No.: 23716237
SIC: 2834 Pharmaceutical Preparations